Navigation Links
C-myc required by the immune system

c-myc, a gene commonly involved in cancer onset, has been found to have a role in the immune system's normal function according to a study published today in Blood. The surprising finding, by a Swiss research team led by investigators from the Lausanne Branch of the international Ludwig Institute for Cancer Research (LICR), showed that c-myc functions in the immune system's 'memory' of previous infections.

In order to rapidly and efficiently respond to new infections, the immune system evolved such that it stores a 'memory' of previous attack by pathogens. The specialized cells involved in this process are known as 'T memory cells'. The T memory cells are normally maintained at a low level that can be rapidly expanded if the pathogen is detected again. The maintenance of normal, low levels, or 'homeostasis', of T memory cells is dependent on a signalling factor, a so-called cytokine, known as 'IL- 15.

"Very little is known about the signalling pathways that actually control IL-15-dependent homeostasis," explains LICR's Dr. H. Robson MacDonald, the senior author of the study. "By analyzing genetically engineered mouse models with reduced c-myc, reduced IL-15 or absent IL-15, we discovered that it's actually c-myc, which is known primarily as an oncogene, that acts downstream of the IL-15 signaling pathway to regulate T memory cell homeostasis."

According to Dr. MacDonald, the study is basic research that may have implications for therapies of the future. "Understanding how immune memory works might allow us to improve therapeutic vaccines against, say, malaria or cancer. The unexpected finding is that this study is also a cautionary tale. Before we design new therapies that inactivate a gene product, which is an approach being considered for c-myc in cancer, we need to be very sure that we are not going to be also destroying a vital role in a normal process such as the body's immune system."


'"/>

Source:Ludwig Institute for Cancer Research


Page: 1

Related biology news :

1. Gene variations explain drug dose required to control seizures
2. B cells are required for development of epithelial cancer associated with chronic inflammation
3. Malignant melanoma cells secrete protein required for embryo formation
4. New study reveals signaling pathways required for expansion of pancreas stem cells
5. Fox Chase Cancer Center scientists identify immune-system mutation
6. Genetically modified natural killer immune cells attack, kill leukemia cells
7. Studies reveal methods viruses use to sidestep immune system
8. Jumping gene helps explain immune systems abilities
9. Scientists solve structure of key protein in innate immune response
10. Rats infected as newborns grew up vulnerable to memory problems during an immune challenge
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/15/2016)... 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... announced today that on December 13, 2016, it received ... Nasdaq Stock Market LLC which acknowledged that, as of ... common stock had been at $1.00 or greater for ... with Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/12/2016)... -- Researchers at Trinity College, Dublin, are opening up ... material with Silly Putty. The mixture (known as "G-putty") ... sense pulse, blood pressure, respiration, and even the ... The research team,s findings were published Thursday in ... Due ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... BELL, Pa. , Jan. 24, 2017 Reha Technology ... at Project Walk – Boston . The need ... as much as it is widely accepted in the surgical space. ... to be an adjunct to traditional therapy and adding technology to ... operational efficiency and have higher gait training repetitions which has been ...
(Date:1/24/2017)... ... , ... Global Food Safety Resource (GFSR) is pleased to kick ... which company CEO Tina Brillinger says features a refreshed interface combined with improved navigation ... “We've spoken to many of our stakeholders and determined that in order to expand ...
(Date:1/24/2017)... Columbus, Ohio (PRWEB) , ... ... ... today announced the release of Version 5.0 of its award-winning CERF ... ELN is a 21CFR11 compliant, collaborative, knowledge asset manager used by laboratories, ...
(Date:1/24/2017)... SANTA CLARA, Calif. , Jan. 24, 2017  Frost & ... chairman of the Fonar Corporation, will receive special recognition at the ... , taking place March 19 to 21, 2017 at the Loews ... To register and download the event agenda for ... www.frost.com/medtech ...
Breaking Biology Technology: